These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
718 related items for PubMed ID: 23039152
1. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. Senbokuya N, Kinouchi H, Kanemaru K, Ohashi Y, Fukamachi A, Yagi S, Shimizu T, Furuya K, Uchida M, Takeuchi N, Nakano S, Koizumi H, Kobayashi C, Fukasawa I, Takahashi T, Kuroda K, Nishiyama Y, Yoshioka H, Horikoshi T. J Neurosurg; 2013 Jan; 118(1):121-30. PubMed ID: 23039152 [Abstract] [Full Text] [Related]
2. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial. Matsuda N, Naraoka M, Ohkuma H, Shimamura N, Ito K, Asano K, Hasegawa S, Takemura A. Cerebrovasc Dis; 2016 Jan; 42(1-2):97-105. PubMed ID: 27070952 [Abstract] [Full Text] [Related]
3. Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report. Suzuki S, Sayama T, Nakamura T, Nishimura H, Ohta M, Inoue T, Mannoji H, Takeshita I. Cerebrovasc Dis; 2011 Jan; 32(1):89-93. PubMed ID: 21677432 [Abstract] [Full Text] [Related]
4. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis. Saber H, Desai A, Palla M, Mohamed W, Seraji-Bozorgzad N, Ibrahim M. J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204 [Abstract] [Full Text] [Related]
5. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial. Yamamoto T, Mori K, Esaki T, Nakao Y, Tokugawa J, Watanabe M. J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471 [Abstract] [Full Text] [Related]
6. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P. J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967 [Abstract] [Full Text] [Related]
7. [The efficiency of cilostazol for cerebral vasospasm following subarachnoid hemorrhage]. Murahashi T, Kamiyama K, Hara K, Ozaki M, Mikamoto M, Nakagaki Y, Nakagaki Y, Nakamura H. No Shinkei Geka; 2013 May; 41(5):393-400. PubMed ID: 23648655 [Abstract] [Full Text] [Related]
8. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V. J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034 [Abstract] [Full Text] [Related]
9. Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model. Yamaguchi-Okada M, Nishizawa S, Mizutani A, Namba H. Cerebrovasc Dis; 2009 Jan; 28(2):135-42. PubMed ID: 19506373 [Abstract] [Full Text] [Related]
10. Cilostazol attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Nishino A, Umegaki M, Fujinaka T, Yoshimine T. Neurol Res; 2010 Oct; 32(8):873-8. PubMed ID: 20350366 [Abstract] [Full Text] [Related]
12. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients. Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T. Cerebrovasc Dis; 2017 Jun; 44(1-2):59-67. PubMed ID: 28463833 [Abstract] [Full Text] [Related]
13. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM. J Neurosurg; 2002 Mar; 96(3):510-4. PubMed ID: 11883835 [Abstract] [Full Text] [Related]
14. Role of Cilostazol in Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage-A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. Bohara S, Garg K, Singh Rajpal PM, Kasliwal M. World Neurosurg; 2021 Jun; 150():161-170. PubMed ID: 33631387 [Abstract] [Full Text] [Related]
15. Dose-Dependent Inhibitory Effects of Cilostazol on Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage. Suzuki H, Nakatsuka Y, Yasuda R, Shiba M, Miura Y, Terashima M, Suzuki Y, Hakozaki K, Goto F, Toma N. Transl Stroke Res; 2019 Aug; 10(4):381-388. PubMed ID: 30033486 [Abstract] [Full Text] [Related]
16. The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: results of a single center prospective Phase II trial. Hänggi D, Liersch J, Turowski B, Yong M, Steiger HJ. J Neurosurg; 2008 Jun; 108(6):1192-9. PubMed ID: 18518727 [Abstract] [Full Text] [Related]
17. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials. Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY. J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823 [Abstract] [Full Text] [Related]
18. The use of nicardipine prolonged release implants (NPRI) in microsurgical clipping after aneurysmal subarachnoid haemorrhage: comparison with endovascular treatment. Schneider UC, Dreher S, Hoffmann KT, Schmiedek P, Kasuya H, Vajkoczy P. Acta Neurochir (Wien); 2011 Nov; 153(11):2119-25. PubMed ID: 21858650 [Abstract] [Full Text] [Related]
19. The relationship between ruptured aneurysm location, subarachnoid hemorrhage clot thickness, and incidence of radiographic or symptomatic vasospasm in patients enrolled in a prospective randomized controlled trial. Abla AA, Wilson DA, Williamson RW, Nakaji P, McDougall CG, Zabramski JM, Albuquerque FC, Spetzler RF. J Neurosurg; 2014 Feb; 120(2):391-7. PubMed ID: 24313610 [Abstract] [Full Text] [Related]